> << CBER Deputy Director had a two-day meeting with BioPort about > "Anthrax > Vaccine" Interesting, huh/ Can we FOIA the meeting minutes? >> > This is hopefully very good news. I have been contacting Dr. Linda Suydam, a deputy commissioner at FDA (in fact I called her today and had Roxane Bates do likewise, as Rox has more names and contact info from people with serious reactions) so maybe she is listening, or better yet realizing there is much about which to be concerned. I've also been forwarding my complaints to Larry Halloran so they will be followed up. Basically, I have been saying to FDA that: 1) DOD isn't following the package insert re reactions and legally needs to (no more doses after systemic reactions), 2) That DOD has removed clinical judgement from those responsible for administering the vaccine, and has promulgated policies (I have copies of an ever increasing series of policies which I will be happy to share: let me know) which tell medical practitioners when (and to whom: not directly to FDA but through the OTSG) to report adverse events; when to treat systemic reactions (and how) while continuing to immunize; when to grant temporary waivers, etc.-- all areas in which DOD has no authority to contravene the existing standards of medical practice. Only people with medical degrees have the legal authority to make those determinations. And "temporary waivers" are a concept with no basis anywhere in medical practice. 3) That reaction rates are enormous and many are serious, and many patients DO describe the same syndrome, whether or not FDA's limited VAERS "costart" terms are capturing them. ( ie, There *is* commonality of symptoms between vaccine recipients.) 4) These reactions in no way correspond to the side effect rates in the package insert (a legal document intended to provide physicians and patients with accurate information about the vaccine, which is used when making a determination of whether to administer the vaccine). The published side effect profile came from an EARLIER VACCINE, not the licensed vaccine, and the Surgeon General now acknowledges the systemic rate as 5% - 35%. This is legally unacceptable. 5) That FDA needs to investigate the serious reactions itself and not rely on bogus reaction reports from DOD which deny the deaths and chronic illnesses which have occurred. 6) That the VAERS system is designed *solely* to alert FDA of possible problems. Discovering a potential problem then necessitates that a careful clinical trial be done to evaluate the effect, if any, and measure its magnitude. The fact that one in every 500 vaccine recipients has filed a VAERS that reached FDA should be enough to trigger such a trial. And since a trial was started (Tripler AMC) 18 months ago, the data should be available now for FDA's review. I did not mention, because I just learned this, that the AVIP put their own people into the committee that evaluated the VAERS (Dr. John Sever's expert committee). And of course Dr. Greg Poland was the guy set up to separately look at VAERS for the AVIP. So how can the VAERS evaluations be considered unbiased? What I am afraid of is this: to cover everyone's butts, FDA will approve a new package insert with corrected side effect rates, except that it claims systemic reactions are temporary and mild (though 90% of systemic reactions were chronic, according to the recent Dover survey of the 9th Airlift squadron) and that permits revaccination after systemic reactions occur. Such a change however, will not affect the fact that the vaccine was used outside of the parameters FDA has approved in the past. Instead, FDA should place a temporary hold on the vaccinations, while it evaluates the situation and obtains additional information. Meryl Nass, MD >